Skip to main content

Methods (1): Participants and Test Methods

  • Chapter
  • First Online:
Diagnostic Test Accuracy Studies in Dementia
  • 315 Accesses

Abstract

This chapter examines the methodology of diagnostic test accuracy studies. It emphasizes the critical importance in defining participants and test methods (diagnostic test and reference standard). The role of pragmatic diagnostic test accuracy studies, recruiting consecutive patients with few exclusion criteria, in comparison to proof-of-concept experimental studies, with patient groups preselected by diagnosis, is emphasized.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:270–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text revision (DSM-IV-TR). Washington: American Psychiatric Association; 2000.

    Google Scholar 

  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. (DSM-5). Washington: American Psychiatric Association; 2013.

    Google Scholar 

  • Armstrong MJ, Litvan I, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80:496–503.

    Article  PubMed  PubMed Central  Google Scholar 

  • Arvanitakis Z, Capuano AW, Leurgans SE, Bennett DA, Schneider JA. Relation of cerebral vessel disease to Alzheimer’s disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol. 2016;15:934–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bachmann LM, Puhan MA, ter Riet G, Bossuyt PM. Sample sizes of studies on diagnostic accuracy: literature survey. BMJ. 2006;332:1127–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • Barberger-Gateau P, Commenges D, Gagnon M, Letenneur L, Sauvel C, Dartigues JF. Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J Am Geriatr Soc. 1992;40:1129–34.

    Article  CAS  PubMed  Google Scholar 

  • Bartlett JW, Frost C, Mattsson N, et al. Determining cut-points for Alzheimer’s disease biomarkers: statistical issues, methods and challenges. Biomark Med. 2012;6:391–400.

    Article  CAS  PubMed  Google Scholar 

  • Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976). 2000;25:3186–91.

    Article  CAS  Google Scholar 

  • Bharambe V, Larner AJ. Functional cognitive disorders: memory clinic study. Prog Neurol Psychiatry. 2018a;22(3):19–22.

    Article  Google Scholar 

  • Bharambe V, Larner AJ. Functional cognitive disorders: demographic and clinical features contribute to a positive diagnosis. Neurodener Dis Manag. 2018b;8:377–83.

    Article  Google Scholar 

  • Brown JM. TYM (Test Your Memory) testing. In: Larner AJ, editor. Cognitive screening instruments. A practical approach. 2nd ed. London: Springer; 2017. p. 209–29.

    Chapter  Google Scholar 

  • Christa Maree Stephan B, Minett T, Pagett E, Siervo M, Brayne C, McKeith IG. Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review. BMJ Open. 2013;3:e001909.

    Article  PubMed  PubMed Central  Google Scholar 

  • Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology. 1992;42:473–80.

    Article  CAS  PubMed  Google Scholar 

  • Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993;269:2386–91.

    Article  CAS  PubMed  Google Scholar 

  • Crutch SJ, Schott JM, Rabinovici GD, et al. Consensus classification of posterior cortical atrophy. Alzheimers Dement. 2017;13:870–84.

    Article  PubMed  PubMed Central  Google Scholar 

  • Cure S, Abrams K, Belger M, Dell’agnello G, Happich M. Systematic literature review and meta-analysis of diagnostic test accuracy in Alzheimer’s disease and other dementia using autopsy as standard of truth. J Alzheimers Dis. 2014;42:169–82.

    Article  PubMed  Google Scholar 

  • Damian AM, Jacobson SA, Hentz JG, et al. The Montreal Cognitive Assessment and the Mini-Mental State Examination as screening instruments for cognitive impairment: item analyses and threshold scores. Dement Geriatr Cogn Disord. 2011;31:126–31.

    Article  PubMed  Google Scholar 

  • Davis DH, Creavin ST, Noel-Storr A, et al. Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies. Cochrane Database Syst Rev. 2013;3:CD010460.

    Google Scholar 

  • De Groot JA, Bossuyt PM, Reitsma JB, et al. Verification problems in diagnostic accuracy studies: consequences and solutions. BMJ. 2011;343:d4770.

    Article  PubMed  Google Scholar 

  • De Mendonca A, Ribeiro F, Guerreiro M, Garcia C. Frontotemporal mild cognitive impairment. J Alzheimers Dis. 2004;6:1–9.

    Article  PubMed  Google Scholar 

  • Doran M, Vinjamuri S, Collins J, Parker D, Larner AJ. SPECT perfusion imaging in the differential diagnosis of dementia: a retrospective regional audit. Int J Clin Pract. 2005;59:496–500.

    Article  CAS  PubMed  Google Scholar 

  • Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007a;6:734–46.

    Article  PubMed  Google Scholar 

  • Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson’s disease dementia: recommendations from the Movement Disorder Society task force. Mov Disord. 2007b;22:2314–24.

    Article  PubMed  Google Scholar 

  • Dubois B, Feldman HH, Jacova C, et al. Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol. 2010;9:1118–27.

    Article  PubMed  Google Scholar 

  • Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614–29. [Erratum Lancet Neurol. 2014;13:757].

    Article  PubMed  Google Scholar 

  • Dufouil C, Clayton D, Brayne C, et al. Population norms for the MMSE in the very old: estimates based on longitudinal data. Mini-Mental State Examination. Neurology. 2000;55:1609–13.

    Article  CAS  PubMed  Google Scholar 

  • Elhadd K, Bharambe V, Larner AJ. Functional cognitive disorders: can sleep disturbance contribute to a positive diagnosis? J Sleep Disord Ther. 2018;7:291.

    Google Scholar 

  • Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord. 2007;22:1689–707.

    Article  PubMed  Google Scholar 

  • Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med. 1997;337:1667–74.

    Article  CAS  PubMed  Google Scholar 

  • Erkinjuntti T, Inzitari D, Pantoni L, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl. 2000;59:23–30.

    CAS  PubMed  Google Scholar 

  • Feher EP, Mahurin RK, Doody RS, Cooke N, Sims J, Pirozzolo FJ. Establishing the limits of the Mini-Mental State Examination. Arch Neurol. 1992;49:87–92.

    Article  CAS  PubMed  Google Scholar 

  • Flicker L, Logiudice D, Carlin JB, Ames D. The predictive value of dementia screening instruments in clinical populations. Int J Geriatr Psychiatry. 1997;12:203–9.

    Article  CAS  PubMed  Google Scholar 

  • Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.

    Article  CAS  PubMed  Google Scholar 

  • Galasko D, Klauber MR, Hofstetter CR, Salmon DP, Lasker B, Thal LJ. The Mini-Mental State Examination in the early diagnosis of Alzheimer’s disease. Arch Neurol. 1990;47:49–52.

    Article  CAS  PubMed  Google Scholar 

  • Galvin JE, Fagan AM, Holtzman DM, Mintun MA, Morris JC. Relationship of dementia screening tests with biomarkers of Alzheimer’s disease. Brain. 2010;133:3290–300.

    Article  PubMed  PubMed Central  Google Scholar 

  • Garcia-Caballero A, Garcia-Lado I, Gonzalez-Hermida J, et al. Validation of the Spanish version of the Addenbrooke’s Cognitive Examination in a rural community in Spain. Int J Geriatr Psychiatry. 2006;21:239–45.

    Article  CAS  PubMed  Google Scholar 

  • Ghadiri-Sani M, Larner AJ. Head turning sign for diagnosis of dementia and mild cognitive impairment: a revalidation. J Neurol Neurosurg Psychiatry. 2013;84:e2.

    Article  Google Scholar 

  • Gifford DR, Cummings JL. Evaluating dementia screening tests. Methodologic standards to rate their performance. Neurology. 1999;52:224–7.

    Article  CAS  PubMed  Google Scholar 

  • Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672–713.

    Article  PubMed  PubMed Central  Google Scholar 

  • Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006–14.

    Article  PubMed  PubMed Central  Google Scholar 

  • Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175:401–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Habib N, Stott J. Systematic review of the diagnostic accuracy of the non-English versions of Addenbrooke’s cognitive examination – revised and III. Aging Ment Health. 2019;23:297–304.

    Article  PubMed  Google Scholar 

  • Hamid S, Larner AJ. For how long should patients with functional cognitive disorder be followed-up? Prog Neurol Psychiatry. 2019;23(1):16–8.

    Article  Google Scholar 

  • Hancock P, Larner AJ. The diagnosis of dementia: diagnostic accuracy of an instrument measuring activities of daily living in a clinic-based population. Dement Geriatr Cogn Disord. 2007;23:133–9.

    Article  CAS  PubMed  Google Scholar 

  • Hancock P, Larner AJ. Diagnostic utility of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and its combination with the Addenbrooke’s Cognitive Examination-Revised (ACE-R) in a memory clinic-based population. Int Psychogeriatr. 2009a;21:526–30.

    Article  CAS  PubMed  Google Scholar 

  • Hancock P, Larner AJ. Clinical utility of Patient Health Questionnaire-9 (PHQ-9) in memory clinics. Int J Psychiatry Clin Pract. 2009b;13:188–91.

    Article  CAS  PubMed  Google Scholar 

  • Hancock P, Larner AJ. Test Your Memory (TYM) test: diagnostic utility in a memory clinic population. Int J Geriatr Psychiatry. 2011;26:976–80.

    Article  CAS  PubMed  Google Scholar 

  • Hancock P, Larner AJ. Cornell Scale for Depression in Dementia: clinical utility in a memory clinic. Int J Psychiatry Clin Pract. 2015;19:71–4.

    Article  PubMed  Google Scholar 

  • Harrell LE, Marson D, Chatterjee A, Parrish JA. The Severe Mini-Mental State Examination: a new neuropsychologic instrument for the bedside assessment of severely impaired patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 2000;14:168–75.

    Article  CAS  PubMed  Google Scholar 

  • Harrison JK, Fearon P, Noel-Storr AH, McShane R, Stott DJ, Quinn TJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) setting. Cochrane Database Syst Rev. 2014;7:CD010771.

    Google Scholar 

  • Harrison JK, Fearon P, Noel-Storr AH, McShane R, Stott DJ, Quinn TJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care setting. Cochrane Database Syst Rev. 2015;3:CD010772.

    Google Scholar 

  • Harrison JK, Stott DJ, McShane R, Noel-Storr AH, Swann-Price RS, Quinn TJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings. Cochrane Database Syst Rev. 2016;11:CD011333.

    PubMed  Google Scholar 

  • Hatfield CF, Dudas RB, Dening T. Diagnostic tools for dementia. Maturitas. 2009;63:181–5.

    Article  PubMed  Google Scholar 

  • Heath CA, Cooper SA, Murray K, et al. Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease. Ann Neurol. 2010;67:761–70.

    PubMed  Google Scholar 

  • Hejl A, Høgh P, Waldemar G. Potentially reversible conditions in 1000 consecutive memory clinic patients. J Neurol Neurosurg Psychiatry. 2002;73:390–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hodges JR, Larner AJ. Addenbrooke’s Cognitive Examinations: ACE, ACE-R, ACE-III, ACEapp, and M-ACE. In: Larner AJ, editor. Cognitive screening instruments. A practical approach. 2nd ed. London: Springer; 2017. p. 109–37.

    Chapter  Google Scholar 

  • Höglinger GU, Respondek G, Stamelou M, et al. Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society criteria. Mov Disord. 2017;32:853–64.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation of the Addenbrooke’s Cognitive Examination III in frontotemporal dementia and Alzheimer’s disease. Dement Geriatr Cogn Disord. 2013;36:242–50.

    Article  PubMed  Google Scholar 

  • Hsieh S, McGrory S, Leslie F, et al. The Mini-Addenbrooke’s Cognitive Examination: a new assessment tool for dementia. Dement Geriatr Cogn Disord. 2015;39:1–11.

    Article  PubMed  Google Scholar 

  • Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinic-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Huppert FA, Brayne C, Gill C, Paykel ES, Beardsall L. CAMCOG: a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample. Br J Clin Psychol. 1995;34:529–41.

    Article  PubMed  Google Scholar 

  • Jorm AF. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): a review. Int Psychogeriatr. 2004;16:275–93.

    Article  PubMed  Google Scholar 

  • Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989;19:1015–22.

    Article  CAS  PubMed  Google Scholar 

  • Julayanont P, Nasreddine ZS. Montreal Cognitive Assessment (MoCA): concept and clinical review. In: Larner AJ, editor. Cognitive screening instruments. A practical approach. 2nd ed. London: Springer; 2017. p. 139–95.

    Chapter  Google Scholar 

  • Kelly T, Larner AJ. Howard Knox (1885-1949): a pioneer of neuropsychological testing. Adv Clin Neurosci Rehabil. 2014;14(5):30–1.

    Google Scholar 

  • Kim GH, Lee JH, Seo SW, et al. Seoul criteria for PiB(−) subcortical vascular dementia based on clinical and MRI variables. Neurology. 2014;82:1529–35.

    Article  PubMed  Google Scholar 

  • Knapskog AB, Barca ML, Engedal K. Prevalence of depression among memory clinic patients as measured by the Cornell Scale of Depression in Dementia. Aging Mental Health. 2014;18:579–87.

    Article  PubMed  Google Scholar 

  • Knottnerus JA, editor. The evidence base of clinical diagnosis. London: BMJ Books; 2002.

    Google Scholar 

  • Knottnerus JA, Muris JW. Assessment of the accuracy of diagnostic tests: the cross-sectional study. In: Knottnerus JA, editor. The evidence base of clinical diagnosis. London: BMJ Books; 2002. p. 39–59.

    Google Scholar 

  • Knottnerus JA, van Weel C. General introduction: evaluation of diagnostic procedures. In: Knottnerus JA, editor. The evidence base of clinical diagnosis. London: BMJ Books; 2002. p. 1–17.

    Google Scholar 

  • Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Larner AJ. Guidelines for primary headache disorders in primary care: an “intervention” study. Headache Care. 2006a;3(1):1–2.

    Article  Google Scholar 

  • Larner AJ. An audit of the Addenbrooke’s Cognitive Examination (ACE) in clinical practice. 2. Longitudinal change. Int J Geriatr Psychiatry. 2006b;21:698–9.

    Article  CAS  PubMed  Google Scholar 

  • Larner AJ. Addenbrooke’s Cognitive Examination (ACE) for the diagnosis and differential diagnosis of dementia. Clin Neurol Neurosurg. 2007a;109:491–4.

    Article  CAS  PubMed  Google Scholar 

  • Larner AJ. Addenbrooke’s Cognitive Examination-Revised (ACE-R) in day-to-day clinical practice. Age Ageing. 2007b;36:685–6.

    Article  CAS  PubMed  Google Scholar 

  • Larner AJ. ACE-R: cross-sectional and longitudinal use for cognitive assessment. In: Fisher A, Hanin I, editors. New trends in Alzheimer and Parkinson related disorders: ADPD 2009. Collection of selected free papers from the 9th International Conference on Alzheimer’s and Parkinson’s disease AD/PD. Prague, Czech Republic, March 11–15, 2009. Bologna: Medimond International Proceedings; 2009. p. 103–7.

    Google Scholar 

  • Larner AJ. Pragmatic diagnostic accuracy studies. http://bmj.com/content/345/bmj.e3999?tab=responses, 28 Aug 2012a.

  • Larner AJ. Neurological signs of ageing. In: Sinclair A, Morley JE, Vellas B, editors. Pathy’s Principles and practice of geriatric medicine. 5th ed. Chichester: Wiley; 2012b. p. 609–16.

    Google Scholar 

  • Larner AJ. Head turning sign: pragmatic utility in clinical diagnosis of cognitive impairment. J Neurol Neurosurg Psychiatry. 2012c;83:852–3.

    Article  CAS  PubMed  Google Scholar 

  • Larner AJ. Can the informant Fluctuation Composite Score help in the diagnosis of synucleinopathies? A pragmatic study. Int J Geriatr Psychiatry. 2012d;27:1094–5.

    Article  CAS  PubMed  Google Scholar 

  • Larner AJ. Screening utility of the Montreal Cognitive Assessment (MoCA): in place of - or as well as - the MMSE? Int Psychogeriatr. 2012e;24:391–6.

    Article  CAS  PubMed  Google Scholar 

  • Larner AJ. Neuropsychological neurology: the neurocognitive impairments of neurological disorders. 2nd ed. Cambridge: Cambridge University Press; 2013a.

    Book  Google Scholar 

  • Larner AJ. Can the Frontal Assessment Battery (FAB) help in the diagnosis of behavioural variant frontotemporal dementia? A pragmatic study. Int J Geriatr Psychiatry. 2013b;28:106–7.

    Article  CAS  PubMed  Google Scholar 

  • Larner AJ. Comparing diagnostic accuracy of cognitive screening instruments: a weighted comparison approach. Dement Geriatr Cogn Disord Extra. 2013c;3:60–5.

    Article  CAS  Google Scholar 

  • Larner AJ. Addenbrooke’s Cognitive Examination-Revised (ACE-R): pragmatic study of cross-sectional use for assessment of cognitive complaints of unknown aetiology. Int J Geriatr Psychiatry. 2013d;28:547–8.

    Article  CAS  PubMed  Google Scholar 

  • Larner AJ. Dementia in clinical practice: a neurological perspective. Pragmatic studies in the cognitive function clinic. 2nd ed. London: Springer; 2014a.

    Book  Google Scholar 

  • Larner AJ. Impact of the National Dementia Strategy in a neurology-led memory clinic: 5-year data. Clin Med. 2014b;14:216.

    Article  CAS  Google Scholar 

  • Larner AJ. Neurological signs of possible diagnostic value in the cognitive disorders clinic. Pract Neurol. 2014c;14:332–5.

    Article  CAS  PubMed  Google Scholar 

  • Larner AJ. AD8 informant questionnaire for cognitive impairment: pragmatic diagnostic test accuracy study. J Geriatr Psychiatry Neurol. 2015a;28:198–202.

    Article  CAS  PubMed  Google Scholar 

  • Larner AJ. Speed versus accuracy in cognitive assessment when using CSIs. Prog Neurol Psychiatry. 2015b;19(1):21–4.

    Article  Google Scholar 

  • Larner AJ. Performance-based cognitive screening instruments: an extended analysis of the time versus accuracy trade-off. Diagnostics (Basel). 2015c;5:504–12.

    Article  Google Scholar 

  • Larner AJ. Mini-Addenbrooke’s Cognitive Examination: a pragmatic diagnostic accuracy study. Int J Geriatr Psychiatry. 2015d;30:547–8.

    Article  CAS  PubMed  Google Scholar 

  • Larner AJ. Optimizing the cutoffs of cognitive screening instruments in pragmatic diagnostic accuracy studies: maximising accuracy or Youden index? Dement Geriatr Cogn Disord. 2015e;39:167–75.

    Article  PubMed  Google Scholar 

  • Larner AJ. Hard-TYM: a pragmatic study. Int J Geriatr Psychiatry. 2015f;30:330–1.

    Article  CAS  PubMed  Google Scholar 

  • Larner AJ. Dementia in clinical practice: a neurological perspective. Pragmatic studies in the cognitive function clinic. 3rd ed. London: Springer; 2018a.

    Book  Google Scholar 

  • Larner AJ. Eponyms revisited. Prog Neurol Psychiatry. 2018;22(4):22.

    Article  Google Scholar 

  • Larner AJ. MACE for diagnosis of dementia and MCI: examining cut-offs and predictive values. Diagnostics (Basel). 2019;9:51.

    Article  Google Scholar 

  • Larner AJ, Mitchell AJ. A meta-analysis of the accuracy of the Addenbrooke’s Cognitive Examination (ACE) and the Addenbrooke’s Cognitive Examination-Revised (ACE-R) in the detection of dementia. Int Psychogeriatr. 2014;26:555–63.

    Article  PubMed  Google Scholar 

  • Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–86.

    Article  CAS  PubMed  Google Scholar 

  • Lees RA, Hendry BK, Broomfield N, Stott D, Larner AJ, Quinn TJ. Cognitive assessment in stroke: feasibility and test properties using differing approaches to scoring of incomplete items. Int J Geriatr Psychiatry. 2017;32:1072–8.

    Article  PubMed  Google Scholar 

  • Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology. 1996;47:1–9.

    Article  CAS  PubMed  Google Scholar 

  • Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012;27:349–56.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lundquist RS, Bernens A, Olsen CG. Comorbid disease in geriatric patients: dementia and depression. Am Fam Physician. 1997;55:2687–94, 2703–2704.

    CAS  PubMed  Google Scholar 

  • Magni E, Binetti G, Bianchetti A, Rozzini R. Mini-mental state examination: a normative study in Italian elderly population. Eur J Neurol. 1996;3:1–5.

    Article  Google Scholar 

  • Malloy PF, Cummings JL, Coffey CE, et al. Cognitive screening instruments in neuropsychiatry: a report of the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci. 1997;9:189–97.

    Article  CAS  PubMed  Google Scholar 

  • Mathew R, Bak TH, Hodges JR. Diagnostic criteria for corticobasal syndrome: a comparative study. J Neurol Neurosurg Psychiatry. 2012;83:405–10.

    Article  PubMed  Google Scholar 

  • Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology. 2000;55:1613–20.

    Article  CAS  PubMed  Google Scholar 

  • Mattis S. Mental status examination for organic mental syndrome in the elderly. In: Bellack R, Karasu B, editors. Geriatric psychiatry. New York: Grune and Stratton; 1976. p. 77–121.

    Google Scholar 

  • Mattis S. Dementia rating scale. Windsor: NFER-Nelson; 1992.

    Google Scholar 

  • Mattsson N, Zetterberg H, Hansson O, et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA. 2009;302:385–93.

    Article  CAS  PubMed  Google Scholar 

  • McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113–24.

    Article  CAS  PubMed  Google Scholar 

  • McKeith IG, Perry EK, Perry RH for the Consortium on Dementia with Lewy Bodies. Report of the second dementia with Lewy body international workshop. Neurology. 1999;53:902–5.

    Article  CAS  PubMed  Google Scholar 

  • McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863–72.

    Article  CAS  PubMed  Google Scholar 

  • McKeith I, O’Brien J, Walker Z, et al. Sensitivity and specificity of dopamine transporter imaging with123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6:305–13.

    Article  PubMed  Google Scholar 

  • McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89:88–100.

    Article  PubMed  PubMed Central  Google Scholar 

  • McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease. Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Service Task forces on Alzheimer’s disease. Neurology. 1984;34:939–44.

    Article  CAS  PubMed  Google Scholar 

  • McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia. Report of the Work Group on Frontotemporal Dementia and Pick’s disease. Arch Neurol. 2001;58:1803–9.

    Article  CAS  PubMed  Google Scholar 

  • McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • Measso G, Cavarzeran F, Zappala G, et al. The Mini-Mental State Examination – normative study of an Italian random sample. Dev Neuropsychol. 1993;9:77–85.

    Article  Google Scholar 

  • Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke’s Cognitive Examination Revised: a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry. 2006;21:1078–85.

    Article  PubMed  Google Scholar 

  • Mitchell AJ. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatr Res. 2009;43:411–31.

    Article  PubMed  Google Scholar 

  • Mitchell AJ. The Mini-Mental State Examination (MMSE): an update on its diagnostic validity for cognitive disorders. In: Larner AJ, editor. Cognitive screening instruments. A practical approach. London: Springer; 2013. p. 15–46.

    Chapter  Google Scholar 

  • Mitchell AJ. The Mini-Mental State Examination (MMSE): update on its diagnostic accuracy and clinical utility for cognitive disorders. In: Larner AJ, editor. Cognitive screening instruments. A practical approach. 2nd ed. London: Springer; 2017. p. 37–48.

    Chapter  Google Scholar 

  • Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia – meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand. 2009;119:252–65.

    Article  CAS  PubMed  Google Scholar 

  • Mohs RC, Knopman D, Petersen RC, et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer’s Disease Assessment Scale that broaden its scope. The Alzheimer’s Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11(Suppl2):S13–21.

    Article  PubMed  Google Scholar 

  • Molloy DW, Alemayehu E, Roberts R. Reliability of a Standardized Mini-Mental State Examination compared with the traditional Mini-Mental State Examination. Am J Psych. 1991;148:102–5.

    Article  CAS  Google Scholar 

  • Molloy DW, Standish TI. A guide to the Standardized Mini-Mental State Examination. Int Psychogeriatr. 1997;9(Suppl1):87–94. discussion 143-50.

    Article  PubMed  Google Scholar 

  • Musso M, Cohen AS, Auster TL, McGovern JE. Investigation of the Montreal Cognitive Assessment (MoCA) as a cognitive screener in severe mental illness. Psychiatry Res. 2014;220:664–8.

    Article  PubMed  Google Scholar 

  • Naaktgeboren CA, de Groot JAH, Rutjes AWS, Bossuyt PMM, Reitsma JB, Moons KGM. Anticipating missing reference standard data when planning diagnostic accuracy studies. BMJ. 2016;352:i402.

    Article  PubMed  PubMed Central  Google Scholar 

  • Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.

    Article  PubMed  Google Scholar 

  • Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–54.

    Article  CAS  PubMed  Google Scholar 

  • Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study. Lancet. 2001;357:169–75.

    Article  Google Scholar 

  • Newman CGJ, Bevins AD, Zajicek JP, et al. Improving the quality of cognitive screening assessments: ACEmobile, an iPad-based version of the Addenbrooke’s Cognitive Examination-III. Alzheimers Dement (Amst). 2017;10:182–7.

    Google Scholar 

  • Noel-Storr AH, Flicker L, Ritchie CW, et al. Systematic review of the body of evidence for use of biomarkers in the diagnosis of dementia. Alzheimers Dement. 2013;9:e96–105.

    Article  PubMed  Google Scholar 

  • Noel-Storr AH, McCleery JM, Richard E, et al. Reporting standards for studies of diagnostic test accuracy in dementia: the STARDdem Initiative. Neurology. 2014;83:364–73.

    Article  PubMed  PubMed Central  Google Scholar 

  • Norman G, Monteiro S, Salama S. Sample size calculations: should the emperor’s clothes be off the peg or made to measure? BMJ. 2012;345:e5728.

    Google Scholar 

  • O’Caoimh R, Gao Y, McGlade C, et al. Comparison of the quick mild cognitive impairment (Qmci) screen and the SMMSE in screening for mild cognitive impairment. Age Ageing. 2012;41:624–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • O’Caoimh R, Gao Y, Svendovski A, Gallagher P, Eustace J, Molloy DW. Comparing approaches to optimize cut-off scores for short cognitive screening instruments in mild cognitive impairment and dementia. J Alzheimers Dis. 2017;57:123–33.

    Article  PubMed  PubMed Central  Google Scholar 

  • Parker C, Philp I. Screening for cognitive impairment among older people in black and minority ethnic groups. Age Ageing. 2004;33:447–52.

    Article  PubMed  Google Scholar 

  • Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–8. [Erratum Arch Neurol. 1999;56:760].

    Article  CAS  PubMed  Google Scholar 

  • Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352:2379–88.

    Article  CAS  PubMed  Google Scholar 

  • Portet F, Ousset PJ, Visser PJ, et al. Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s Disease. J Neurol Neurosurg Psychiatry. 2006;77:714–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Quinn TJ, Fearon P, Noel-Storr AH, Young C, McShane R, Stott DJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations. Cochrane Database Syst Rev. 2014;4:CD010079.

    Google Scholar 

  • Ramia JM, Ruiz-Gomez F, De la Plaza R, Veguillas P, Quinones J, Garcia-Parreno J. Ambispective comparative study of two surgical strategies for liver hydatidosis. World J Gastroenterol. 2012;18:546–50.

    Article  PubMed  PubMed Central  Google Scholar 

  • Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456–77.

    Article  PubMed  PubMed Central  Google Scholar 

  • Reilmann R, Leavitt BR, Ross CA. Diagnostic criteria for Huntington’s disease based on natural history. Mov Disord. 2014;29:1335–41.

    Article  PubMed  Google Scholar 

  • Reisberg B, Prichep L, Mosconi L, et al. The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer’s disease. Alzheimers Dement. 2008;4(1Suppl1):S98–108.

    Article  PubMed  Google Scholar 

  • Roalf DR, Moore TM, Wolk DA, et al. Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease. J Neurol Neurosurg Psychiatry. 2016;87:1303–10.

    Article  PubMed  Google Scholar 

  • Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology. 1993;43:250–60.

    Article  PubMed  Google Scholar 

  • Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry. 1984;141:1356–64.

    Article  CAS  PubMed  Google Scholar 

  • Rossetti HC, Lacritz LH, Cullum CM, Weiner MF. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology. 2011;77:1272–5.

    Article  PubMed  Google Scholar 

  • Roth M, Huppert FA, Mountjoy CQ, Tym E. CAMDEX-R. The revised Cambridge Examination for Mental Disorders of the Elderly. 2nd ed. Cambridge: Cambridge University Press; 1999.

    Google Scholar 

  • Rutjes AW, Reitsma JB, Di Nisio M, Smidt N, van Rijn JC, Bossuyt PM. Evidence of bias and variation in diagnostic accuracy studies. CMAJ. 2006;174:469–76.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sachdev P, Kalaria R, O’Brien J, et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;28:206–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sackett DL, Haynes RB. The architecture of diagnostic research. In: Knottnerus JA, editor. The evidence base of clinical diagnosis. London: BMJ Books; 2002. p. 19–38.

    Google Scholar 

  • Schneider JA, Aggarwal NT, Barnes L, Boyle P, Bennett DA. The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis. 2009;18:691–701.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sells R, Larner AJ. The Poppelreuter figure visual perceptual function test for dementia diagnosis. Prog Neurol Psychiatry. 2011;15(2):17–18, 20–21.

    Article  Google Scholar 

  • Simard M. The Mini-Mental State Examination: strengths and weaknesses of a clinical instrument. Can Rev Alzheimers Dis Other Demen. 1998;2(3):10–2.

    Google Scholar 

  • Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer’s disease. The Nun Study. JAMA. 1997;277:813–7.

    Article  CAS  PubMed  Google Scholar 

  • Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:280–92.

    Article  PubMed  PubMed Central  Google Scholar 

  • Stagg B, Larner AJ. Zarit Burden Interview: pragmatic study in a dedicated cognitive function clinic. Prog Neurol Psychiatry. 2015;19(4):23–7.

    Article  Google Scholar 

  • Steenland K, Macneil J, Bartell S, Lah J. Analyses of diagnostic patterns at 30 Alzheimer’s Disease Centers in the US. Neuroepidemiology. 2010;35:19–27.

    Article  PubMed  PubMed Central  Google Scholar 

  • Stern RA, White T. Neuropsychological assessment battery. Lutz, FL: Psychological Assessment Resources, Inc.; 2003.

    Google Scholar 

  • Stone J, Pal S, Blackburn D, Reuber M, Thekkumpurath P, Carson A. Functional (psychogenic) cognitive disorders: a perspective from the neurology clinic. J Alzheimers Dis. 2015;48(Suppl1):S5–17.

    Article  PubMed  Google Scholar 

  • Strong MJ, Grace GM, Freedman M, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:131–46.

    Article  PubMed  Google Scholar 

  • Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48:314–8.

    CAS  PubMed  Google Scholar 

  • The Ronald and Nancy Reagan Research Institute of the Alzheimer’s Association and the National Institute on Aging Working Group. Consensus report of the Working Group on: “Molecular and biochemical markers of Alzheimer’s disease”. Neurobiol Aging. 1998;19:109–16.

    Article  Google Scholar 

  • Upadhyaya AK, Rajagopal M, Gale TM. The Six Item Cognitive Impairment Test (6-CIT) as a screening test for dementia: comparison with Mini-Mental State Examination (MMSE). Curr Aging Sci. 2010;3:138–42.

    Article  PubMed  Google Scholar 

  • van der Linde RM, Stephan BCM, Dening T, Brayne C. Instruments to measure behavioural and psychological symptoms of dementia. Int J Methods Psychiatr Res. 2014;23:69–98.

    Article  PubMed  PubMed Central  Google Scholar 

  • van Straaten EC, Scheltens P, Knol DL, et al. Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study. Stroke. 2003;34:1907–12.

    Article  PubMed  Google Scholar 

  • Warren JD, Schott JM, Fox NC, et al. Brain biopsy in dementia. Brain. 2005;128:2016–25.

    Article  CAS  PubMed  Google Scholar 

  • Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240–6.

    Article  CAS  PubMed  Google Scholar 

  • Wong SH, Jenkinson MD, Faragher B, Thomas S, Crooks D, Solomon T. Brain biopsy in the management of neurology patients. Eur Neurol. 2010;64:42–5.

    Article  CAS  PubMed  Google Scholar 

  • World Health Organization. ICD-10. International statistical classification of diseases and related health problems: tenth revision. 2nd ed. Geneva: World Health Organization; 2004.

    Google Scholar 

  • Wragg RE, Jeste DV. Overview of depression and psychosis in Alzheimer’s disease. Am J Psychiatry. 1989;146:577–87.

    Article  CAS  PubMed  Google Scholar 

  • Ylikoski R, Erkinjuntti T, Sulkava R, Juva K, Tilvis R, Valvanne J. Correction for age, education and other demographic variables in the use of the Mini Mental State Examination in Finland. Acta Neurol Scand. 1992;85:391–6.

    Article  CAS  PubMed  Google Scholar 

  • Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132:2659–68. [Erratum Brain. 2012;135:1335].

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Larner, A.J. (2019). Methods (1): Participants and Test Methods. In: Diagnostic Test Accuracy Studies in Dementia. Springer, Cham. https://doi.org/10.1007/978-3-030-17562-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-17562-7_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-17561-0

  • Online ISBN: 978-3-030-17562-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics